Healthy Inc > Blog > Rheumatoid Arthritis treatment
Posted on:

What is leflunomide 20 mg used for?

In the pharmaceutical industry, Leflunomide 20 mg is a potent Disease-Modifying Antirheumatic Drug (DMARD). As a pharmacist, I classify this as an “immunomodulatory” agent. Unlike NSAIDs which only mask pain, Leflunomide is designed to slow down the underlying disease progression and prevent structural joint damage.

Primary Clinical Uses

  • Active Rheumatoid Arthritis (RA): The primary indication for reducing signs and symptoms and inhibiting structural damage (joint erosion and joint space narrowing).

  • Psoriatic Arthritis (PsA): Used to treat the joint inflammation associated with psoriasis, improving physical function and reducing skin involvement.

  • Lupus Nephritis (Off-label): Occasionally used in specialized rheumatology for refractory cases of SLE where other treatments have failed.

Mechanism of Action: Inhibiting Pyrimidine Synthesis

Leflunomide is a prodrug that is rapidly converted in the intestinal wall and liver to its active metabolite, teriflunomide.

Enzyme Inhibition: It inhibits the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH).

Pyrimidine Depletion: This enzyme is essential for the de novo synthesis of uridine monophosphate (rUMP), a building block for DNA and RNA.

Lymphocyte Suppression: Rapidly dividing cells, like activated T-lymphocytes (which cause the inflammation in RA), depend on this de novo pathway. By cutting off their supply of pyrimidines, Leflunomide effectively “starves” the overactive immune cells, reducing joint inflammation without suppressing the rest of the immune system as severely as some other drugs.

The Manufacturer’s Perspective: Technical & Export Details

From a production and global trade standpoint, Leflunomide requires specific professional handling:

  • The Loading Dose vs. Maintenance: Historically, a 100 mg “loading dose” was used for three days, but most modern protocols start directly with the 20 mg maintenance dose to reduce GI side effects. In your Product Information Leaflet (PIL), it is vital to reflect current clinical guidelines for your B2B buyers.

  • Teratogenicity & “Washout” Procedures: Leflunomide has a very long half-life (up to 2 weeks) and is highly teratogenic. As a manufacturer, we must include strict warnings and the Cholestyramine washout protocol in our documentation to ensure safety for patients of childbearing age.

  • Stability for Export: Leflunomide is relatively stable but sensitive to moisture. We utilize Alu-Alu blister packaging at our WHO-GMP facility to ensure a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: This is a high-value item in the rheumatology segment. Our Mumbai facility provides full CTD/eCTD Dossiers to support registration against the innovator (Arava).

Leflunomide Tablets

Posted on:

What is Chloroquine Phosphate 250mg used for?

In the pharmaceutical industry, Chloroquine Phosphate 250 mg (equivalent to 150 mg of Chloroquine base) is a 4-aminoquinoline derivative that has served as a foundational antimalarial and amebicidal agent for decades. As a pharmacist, I characterize Chloroquine as a high-volume essential medicine that remains a first-line choice in regions where parasite sensitivity is still maintained.

Primary Clinical Uses

  • Prophylaxis and Treatment of Malaria: Indicated for the prevention and treatment of acute attacks of malaria caused by Plasmodium vivax, P. malariae, P. ovale, and susceptible strains of P. falciparum.

  • Extra-intestinal Amebiasis: Specifically used to treat amebic liver abscesses caused by Entamoeba histolytica when other treatments are not suitable.

  • Autoimmune Disorders: Frequently used off-label or as a secondary therapy for Rheumatoid Arthritis and Systemic Lupus Erythematosus (SLE) due to its mild immunosuppressive and anti-inflammatory properties.

Mechanism of Action

Chloroquine acts as a blood schizontocide. It enters the malaria parasite’s acidic food vacuole and inhibits the enzyme heme polymerase.

Normally, the parasite digests host hemoglobin and releases toxic free heme, which it then detoxifies into non-toxic hemozoin (malaria pigment). Chloroquine prevents this detoxification; the resulting accumulation of free heme is highly toxic, leading to the rapid lysis and death of the parasite.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Chloroquine Phosphate is a staple of high-capacity production:

  • API Purity & Standardization: As a WHO-GMP manufacturer, we ensure the API meets BP/USP/IP monographs, specifically monitoring for related substances and heavy metals to ensure long-term safety in chronic users.

  • Stability for Global Trade: Chloroquine is a robust molecule. We utilize PVC/PVDC or Alu-Alu blister packaging to ensure a stable 36-month shelf life, facilitating bulk exports to Zone IVb climates (Africa, SE Asia).

  • Volume and Tender Supply: Due to its cost-effective profile, Chloroquine 250 mg is a high-volume item for government health tenders and B2B distributors. Our Mumbai-based facility is optimized for the scale required for these large-scale international contracts.

  • Dossier Support: We provide comprehensive CTD/eCTD Dossiers to assist international partners in the registration process, ensuring compliance with global regulatory standards.

Chloroquine Phosphate Tablets

Add to cart